Therapeutic effectiveness against mopc—315 plasmacytoma of low or high doses of the synthetic thymic hormone THF—γ2 in combination with an “immunomodulating” or a “non—immunomodulating” drug

In view of the established properties of THF-γ2 in the restoration of immunocompetence, we attempted in the present work to determine whether an increase in the dose of THF-γ2 would render chemotherapy with 5-FU more effective. Concomitantly, we determined the effect of low or high doses of THF-γ2 in combination with L-PAM